this Starlite 1 and Starlite 2
must be nearabout
think i saw H2 2024, not sure if that's 1 or 2 though
too many cakes baking .....
Merck and Telix are continuing the initial scientific collaboration to further exploreand optimise the combination of TLX250 or other next-generation targeted radiationtherapy candidates with Merck's DDRi compounds in preclinical studies. About TLX250 TLX250 ((177) Lu-DOTA-girentuximab) is an antibody-based therapeutic platform thattargets CAIX, a cell surface protein that is highly expressed in several human cancers,and is currently the subject of the STARLITE-1 (ClinicalTrials.gov Identifier:NCT05663710) and STARLITE-2 (NCT05239533) studies in combination with immunotherapy.([2])High CAIX tumour expression is generally correlated with poor prognosis. Telix's companion investigational diagnostic imaging agent TLX250-CDx ((89)Zr-DFO-girentuximab) was the subject of a successful global Phase III trial (ZIRCONtrial, NCT03849118), which completed enrolment and reported positive top-line data during2022.([3]) Analyses of primary endpoints and key secondary endpoints of the ZIRCON trialwere presented to the medical community for the first time at ASCO GU on 18 February2023.([4]) TLX250-CDx is currently being investigated in the Phase II STARBURST study(ClinicalTrials.gov Identifier: NCT05563272) exploring CAIX expression in patients with adiverse range of solid tumours for potential diagnostic and therapeuticapplications.([5]) About Telix Pharmaceuticals Limited
- Forums
- ASX - By Stock
- Understanding Telix
this Starlite 1 and Starlite 2must be nearabout think i saw H2...
-
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.79 |
Change
-1.180(5.91%) |
Mkt cap ! $6.287B |
Open | High | Low | Value | Volume |
$20.06 | $20.06 | $18.79 | $33.24M | 1.725M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1999 | $18.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.80 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1999 | 18.790 |
1 | 376 | 18.780 |
5 | 17015 | 18.770 |
2 | 6900 | 18.760 |
7 | 10795 | 18.750 |
Price($) | Vol. | No. |
---|---|---|
18.800 | 1500 | 1 |
18.870 | 67 | 1 |
18.880 | 400 | 1 |
18.930 | 5303 | 3 |
18.940 | 1173 | 2 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online